Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Marlene Plüß"'
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
In recent years, advances in the treatment and management of patients with systemic lupus erythematosus (SLE) have improved their life expectancy and quality of life. However, lupus nephritis (LN) still represents a major life-threatening complicatio
Externí odkaz:
https://doaj.org/article/dccc61c9e2fe495391429f2e94a42521
Autor:
Ann‐Kathrin Schäfer, Tim Kuczera, Rebecca Wurm‐Kuczera, Dieter Müller, Ellen Born, Mark Lipphardt, Marlene Plüss, Manuel Wallbach, Michael Koziolek
Publikováno v:
The Journal of Clinical Hypertension, Vol 23, Iss 7, Pp 1363-1371 (2021)
Abstract Uncontrolled hypertension is a main risk factor for cardiovascular morbidity. Baroreflex activation therapy (BAT) is an effective therapy option addressing true resistant hypertension. We evaluated patients’ eligibility for BAT in a staged
Externí odkaz:
https://doaj.org/article/835db5115d93445eb54cfd636d01a5a7
Autor:
Marlene Plüß, Désirée Tampe, Harald Schwörer, Sebastian Christopher Benjamin Bremer, Björn Tampe
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Potassium para-aminobenzoate (POTABA) is used to treat Peyronie’s disease by decreasing fibrosis and plaque size progression. Among potential side effects, drug-induced liver injury (DILI) attributed to POTABA administration has been reported in a
Externí odkaz:
https://doaj.org/article/57ba4c5274df4e4dbaea872597a4b75d
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
While the global pandemic caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is still ongoing and new virus variants are emerging, there is a universal need for vaccines to protect individuals from severe complications and id
Externí odkaz:
https://doaj.org/article/4e79496ff1174cb1b07372342b32d932
Publikováno v:
BMC Rheumatology, Vol 4, Iss 1, Pp 1-6 (2020)
Abstract Background Rheumatoid arthritis is the most common type of inflammatory arthritis affecting about 1% of the population. With the advent of disease-modifying anti-rheumatic drugs the disease can be well controlled in many cases. Patients, how
Externí odkaz:
https://doaj.org/article/20105b4c59f64f94a2a97fec2cee13cf
Autor:
Marlene Plüß, Kemal Mese, Johannes T. Kowallick, Andreas Schuster, Désirée Tampe, Björn Tampe
Publikováno v:
Frontiers in Immunology, Vol 12 (2022)
As the coronavirus disease 2019 (COVID-19) pandemic is ongoing and new variants of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) are emerging, there is an urgent need for vaccines to protect individuals at high risk for complicati
Externí odkaz:
https://doaj.org/article/6b7a5f69ce5243a1823274ce76e86f8b
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Background and Objectives: Belimumab (BEL) is a monoclonal antibody approved for the treatment of active systemic lupus erythematosus (SLE) but not for lupus nephritis (LN) and neuropsychiatric systemic lupus erythematosus (NPSLE). We aimed to assess
Externí odkaz:
https://doaj.org/article/d369c78d9aa24bdb9fc4ca4f2733f671
Systemic lupus erythematosus (SLE) is a clinically heterogeneous autoimmune disease, and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to standard treatment. Therefore, new agents are required to allow for a mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbade5c2389982be160608ee52c6839d
https://doi.org/10.20944/preprints202205.0128.v1
https://doi.org/10.20944/preprints202205.0128.v1
Publikováno v:
The journal of vascular access.
Background: We have previously reported that the rapid atrial swirl sign (RASS) is an accurate and safe procedure for ultrasound (US)-guided tip positioning of retrograde-tunneled hemodialysis catheters (HDCs). However, application of RASS for placem
Publikováno v:
Der Nephrologe